tinea%20capitis
TINEA CAPITIS
Tinea capitis  is a contagious dermatophytosis affecting the hair shaft and follicles of the scalp, eyebrows and eyelashes.
It is most common in the crowded areas as infection originates from contact with a pet or an infected person and asymptomatic carriage persists indefinitely.
It primarily affects children 3-7 years of age.
The causative agents are the genus Trichophyton and Microsporum.
Cardinal clinical feature is the combination of inflammation with hair breakage and loss.
  1. Berg D, Erickson P. Fungal infections in children: new developments and treatments. Postgrad Med. 2001 Jul;110(1):83-84,87-88,93-94. PMID: 11467045
  2. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol. 2000 Jan;41(1)(Pt 1):1-20. PMID: 10607315
  3. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician. 2008 May;77(10):1415-1420. PMID: 18533375
  4. Fuller LC, Child FJ, Midgley G, et al. Diagnosis and management of scalp ringworm. Br Med J. 2003 Mar;326(7388):539-541. PMID: 12623917
  5. Elewski BE. Treatment of tinea capitis: beyond griseofulvin. J Am Acad Dermatol. 1999 Jun;40(6)(Pt 2):S27-S30. PMID: 10367913
  6. Hainer BL. Dermatophyte infections. Am Fam Physician. 2003 Jan;67(1):101-108. PMID: 12537173
  7. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol. 2000 Jul;143(1):53-58. PMID: 10886135
  8. Raimer SS. New and emerging therapies in pediatric dermatology. Dermatol Clin. 2000 Jan;18(1):73-78. PMID: 10626113
  9. Moossavi M, Bagheri B, Scher RK. Systemic antifungal therapy. Dermatol Clin. 2001 Jan;19(1):35-52. PMID: 11155585
  10. Sladden M, Johnston G. Common skin infections in children. Br Med J. 2004 Jul;329(7457):329, 95-99. PMID: 15242915
  11. Strober BE. Tinea capitis. Dermatol Online J. 2001 Feb;7(1):12. PMID: 11328633
  12. Vander-Straten MR, Hossain MA, Ghannoum MA. Cutaneous infections: dermatophytosis, onychomycosis and tinea versicolor. Infect Dis Clin N Am. 2003 Mar;17(1):87-112. PMID: 12751262
  13. Aaron DM. Tinea capitis. Merck Manual; 2013 Mar. http://www.merckmanuals.com/professional/dermatologic_disorders/fungal_skin_infections/tinea_capitis.html. Accessed 23 Aug 2013
  14. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford guide to antimicrobial therapy. 37th ed. Sperryville, VA: Antimicrobial Therapy Inc; 2007
  15. Habif TP. Superficial fungal infections. Clinical dermatology: a color guide to diagnosis and therapy. 4th ed. Pennsylvania: Mosby, Elsevier; 2004:409-439
  16. MedWormhttp://www.medworm.com/rss/index.php/Dermatology/12/http://www.medworm.com/rss/medicalfeeds/specialities/Dermatology.xml
  17. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  18. Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. UpToDate. http://www.uptodate.com/contents/dermatophyte-tinea-infections. Jul 2013. Accessed 23 Aug 2013
  19. Kao GF. Tinea capitis. eMedicine. http://www.emedicine. com/DERM/topic420.htm
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
16 Mar 2017
Probiotics have a long history of use in humans. Defined as "live organisms that confer a health benefit on the host when administered in adequate amounts", the spectrum of use of probiotics in humans ranges from foods and dietary supplements to pharmaceutical/nutraceutical products to affect general health and disease. While the genera Lactobacillus and Bifidobacterium are the two most common probiotics associated with consumer products, there exist other organisms (eg, the yeast Saccharomyces cerevisiae, some non-pathogenic strains of Escherichia coli and Bacillus species) that are used as probiotics.1–3 One of them is the probiotic strain B. clausii that has been found to be effective for the treatment of diarrhoea and antibiotic-associated gastrointestinal side effects.4–6
Stephen Padilla, 06 Dec 2016
Dengvaxia, a recombinant, live-attenuated dengue vaccine, has the potential to bring down the number of hospitalizations by 13 to 25 percent and be cost-effective in areas of moderate-to-high dengue endemicity, according to a model comparison study.
06 Nov 2017
Treatment with rifaximin appears to effectively prevent spontaneous bacterial peritonitis in patients with cirrhosis and ascites compared with systemically absorbed antibiotics and placebo, a study has found.